XML 45 R36.htm IDEA: XBRL DOCUMENT v3.6.0.2
Business, Basis of Presentation and Business Combinations (Details Textual)
 1 Months Ended 3 Months Ended 12 Months Ended
Oct. 05, 2015
USD ($)
Apr. 28, 2016
USD ($)
$ / shares
shares
Oct. 31, 2015
USD ($)
Sep. 30, 2015
USD ($)
May 31, 2015
USD ($)
Sep. 30, 2016
USD ($)
Sep. 30, 2015
USD ($)
Jun. 30, 2016
USD ($)
Jun. 30, 2015
USD ($)
Apr. 28, 2016
CAD
CAD / shares
May 20, 2015
USD ($)
Business Acquisition [Line Items]                      
Stockholders' Equity, Reverse Stock Split           On June 8, 2015, we reincorporated as a domestic Delaware corporation under Delaware General Corporate Law and changed our name from Rosewind Corporation to Aytu BioScience, Inc., and effected a reverse stock split in which each common stockholder received one share of common stock for every 12.174 shares outstanding. On June 30, 2016, Aytu effected another reverse stock split in which each common stockholder received one share of common stock for every 12 shares outstanding (herein referred to collectively as the Reverse Stock Splits). All share and per share amounts in this report have been adjusted to reflect the effect of these Reverse Stock Splits.   On June 8, 2015, we reincorporated as a domestic Delaware corporation under Delaware General Corporate Law and changed our name from Rosewind Corporation to Aytu BioScience, Inc., and effected a reverse stock split in which each common stockholder received one share of common stock for every 12.174 shares outstanding. On June 30, 2016, Aytu effected another reverse stock split in which each common stockholder received one share of common stock for every 12 shares outstanding (herein referred to collectively as the Reverse Stock Splits).      
Payments to Acquire Businesses, Gross               $ 0 $ 1,000,000    
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset               0 664,000    
Amortization of Intangible Assets $ 174,000         $ 437,014 $ 57,447 664,707 90,662    
Business Combination, Contingent Consideration, Liability, Total               701,000      
Accretion Expense               620,325 $ 620,325    
Developed Technology Rights [Member]                      
Business Acquisition [Line Items]                      
Amortization of Intangible Assets           520,000   520,000      
Trade Names [Member]                      
Business Acquisition [Line Items]                      
Amortization of Intangible Assets           140,000   140,000      
Customer Contracts [Member]                      
Business Acquisition [Line Items]                      
Amortization of Intangible Assets           810,000   810,000      
Prosta Scint [Member]                      
Business Acquisition [Line Items]                      
Payments to Acquire Businesses, Gross     $ 500,000                
Business Combination Consideration Transferred Inventory     102,000         102,000      
Business Combination Consideration Transferred Product Inventory     40,000                
Business Combination Consideration Transferred Work In Process Inventory               80,000      
Amortization expense               159,000      
Prostascint Business [Member]                      
Business Acquisition [Line Items]                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Total         $ 2,400,000           $ 2,391,000
Payments to Acquire Businesses, Gross         1,000,000            
Business Combination, Consideration Transferred, Liabilities Incurred       $ 227,000 227,000            
Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High         $ 2,500,000            
Business Combination Contingent Consideration Percentage         8.00%            
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset         $ 664,000 714,000   699,000      
Amortization of Intangible Assets           40,000 40,000        
Business Combination Consideration Transferred Product Inventory         $ 500,000            
Jazz Pharmaceuticals Inc [Member] | Prosta Scint [Member] | Developed Technology Rights [Member]                      
Business Acquisition [Line Items]                      
Finite-Lived Intangible Assets, Gross           790,000   790,000      
Jazz Pharmaceuticals Inc [Member] | Prosta Scint [Member] | Trade Names [Member]                      
Business Acquisition [Line Items]                      
Finite-Lived Intangible Assets, Gross           80,000   80,000      
Jazz Pharmaceuticals Inc [Member] | Prosta Scint [Member] | Customer Contracts [Member]                      
Business Acquisition [Line Items]                      
Finite-Lived Intangible Assets, Gross           720,000   720,000      
Primsol Business [Member]                      
Business Acquisition [Line Items]                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Total $ 1,799,000                    
Payments to Acquire Businesses, Gross     500,000                
Business Combination, Consideration Transferred, Liabilities Incurred     142,000     1,900,000   1,892,000      
Amortization of Intangible Assets           61,000 $ 0        
Business Combination Consideration Transferred Inventory     102,000     102,000          
Business Combination Consideration Transferred Product Inventory     40,000                
Business Combination Consideration Transferred Work In Process Inventory           80,000          
Primsol Business [Member] | Paid on April 1, 2016 [Member]                      
Business Acquisition [Line Items]                      
Business Combination, Consideration Transferred, Liabilities Incurred     500,000                
Primsol Business [Member] | No Later Than July 01, 2016 [Member]                      
Business Acquisition [Line Items]                      
Business Combination, Consideration Transferred, Liabilities Incurred     500,000                
Primsol Business [Member] | No Later Than November 30, 2016 [Member]                      
Business Acquisition [Line Items]                      
Business Combination, Consideration Transferred, Liabilities Incurred     250,000                
Primsol Business [Member] | No Later Than September 30 2016 [Member]                      
Business Acquisition [Line Items]                      
Business Combination, Consideration Transferred, Liabilities Incurred     $ 250,000                
Natesto [Member]                      
Business Acquisition [Line Items]                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Total           10,500,000   10,500,000      
Payments to Acquire Businesses, Gross   $ 2,000,000           5,400,000      
Business Combination, Consideration Transferred, Liabilities Incurred           3,200,000   3,200,000      
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset           3,200,000   $ 3,200,000      
Amortization of Intangible Assets           330,000          
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | shares   12,245,411                  
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned   $ 2,000,000               CAD 2,534,800  
Business Acquisition, Share Price | (per share)   $ 0.16               CAD 0.207  
One Time Non-Refundable Payments   $ 37,500,000                  
Other Accrued Liabilities           306,000          
Accretion Expense           46,000          
Natesto [Member] | First Milestone [Member] | License And Supply Agreement [Member]                      
Business Acquisition [Line Items]                      
One Time Non-Refundable Payments   2,500,000                  
Sales Revenue Target   25,000,000                  
Natesto [Member] | Second Milestone [Member] | License And Supply Agreement [Member]                      
Business Acquisition [Line Items]                      
One Time Non-Refundable Payments   5,000,000                  
Sales Revenue Target   50,000,000       $ 5,700,000          
Natesto [Member] | Third Milestone [Member] | License And Supply Agreement [Member]                      
Business Acquisition [Line Items]                      
One Time Non-Refundable Payments   7,500,000                  
Sales Revenue Target   75,000,000                  
Natesto [Member] | Forth Milestone [Member] | License And Supply Agreement [Member]                      
Business Acquisition [Line Items]                      
One Time Non-Refundable Payments   10,000,000                  
Sales Revenue Target   100,000,000                  
Natesto [Member] | Fifth Milestone [Member] | License And Supply Agreement [Member]                      
Business Acquisition [Line Items]                      
One Time Non-Refundable Payments   12,500,000                  
Sales Revenue Target   125,000,000                  
Natesto [Member] | Second Upfront [Member]                      
Business Acquisition [Line Items]                      
Business Combination, Consideration Transferred, Liabilities Incurred   2,000,000                  
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned   2,000,000                  
Natesto [Member] | Third Upfront [Member]                      
Business Acquisition [Line Items]                      
Business Combination, Consideration Transferred, Liabilities Incurred   $ 4,000,000